cGKI β Antibodies

Santa Cruz Biotechnology provides a broad selection of cGKI β monoclonal antibodies for research focused on understanding cGKI β protein function. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). cGKI β (cyclic GMP-dependent protein kinase I beta) plays a crucial role in mediating the effects of nitric oxide and cyclic GMP signaling pathways, which are vital for numerous physiological processes, including vascular smooth muscle relaxation and neuronal signaling. cGKI β function is essential for maintaining cardiovascular health and regulating blood pressure, making it a significant target for research in cardiovascular diseases and other related conditions. Understanding cGKI β signaling pathways can provide critical insights into various pathological conditions. Researchers studying cGKI β can explore its role in different tissue types and cellular processes. Advanced research techniques using cGKI β monoclonal antibodies enable detailed investigation of protein expression and localization patterns. Santa Cruz Biotechnology monoclonal antibodies for cGKI β support researchers worldwide in advancing scientific understanding of cardiovascular health and disease mechanisms.